Top Biotechnology companies in Denmark by Price to Sales Ratio (P/S)
Denmark
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
865.40 |
Jan. 14, 2025 | USD 3.98 | 0.01% |
|
Denmark |
|
| 2 |
133.44 |
Jan. 14, 2025 | USD 95.84 | 0.08% |
|
Denmark |
|
| 3 |
49.14 |
Jan. 14, 2025 | USD 91.43 | -1.85% |
|
Denmark |
|
| 4 |
38.91 |
Jan. 14, 2025 | USD 0.57 | 1.47% |
|
Denmark |
|
| 5 |
20.89 |
Jan. 14, 2025 | USD 70.50 | 0.61% |
|
Denmark |
|
| 6 |
19.16 |
Jan. 14, 2025 | USD 0.20 | -2.77% |
|
Denmark |
|
| 7 |
14.42 |
Jan. 14, 2025 | USD 1.93 | -6.19% |
|
Denmark |
|
| 8 |
9.49 |
Jan. 14, 2025 | USD 54.16 | -1.39% |
|
Denmark |
|
| 9 |
9.16 |
Jan. 14, 2025 | USD 0.63 | -3.68% |
|
Denmark |
|
| 10 |
8.31 |
Jan. 14, 2025 | USD 2.17 | 5.88% |
|
Denmark |
|
| 11 |
5.65 |
Jan. 14, 2025 | USD 216.88 | 1.28% |
|
Denmark |
|
| 12 |
2.00 |
Jan. 14, 2025 | USD 26.62 | -0.36% |
|
Denmark |
|
| 13 |
1.77 |
Jan. 14, 2025 | USD 5.46 | 0.56% |
|
Denmark |
Frequently Asked Questions
-
Which Biotechnology company in Denmark has the highest Price to Sales Ratio (P/S) ?
The Biotechnology company in Denmark with the highest Price to Sales Ratio (P/S) is FluoGuide A/S (Stockholm Stock Exchange: FLUO.ST) at 865.40.
-
Which Biotechnology company in Denmark has the lowest Price to Sales Ratio (P/S) ?
The Biotechnology company in Denmark with the lowest Price to Sales Ratio (P/S) is H. Lundbeck A/S (Copenhagen Stock Exchange: HLUN-B.CO) at 1.77.
-
What are the top 10 Biotechnology companies in Denmark by Price to Sales Ratio (P/S) ?
The top 10 Biotechnology companies in Denmark by Price to Sales Ratio (P/S) are FluoGuide A/S, Zealand Pharma A/S, Gubra A/S, Saniona AB (publ), ChemoMetec A/S, BioPorto A/S, ViroGates A/S, Novozymes A/S, BactiQuant A/S and ExpreS2ion Biotech Holding AB (publ).
-
What are the bottom 10 Biotechnology companies in Denmark by Price to Sales Ratio (P/S) ?
The bottom 10 Biotechnology companies in Denmark by Price to Sales Ratio (P/S) are H. Lundbeck A/S, Bavarian Nordic A/S, Genmab A/S, ExpreS2ion Biotech Holding AB (publ), BactiQuant A/S, Novozymes A/S, ViroGates A/S, BioPorto A/S, ChemoMetec A/S and Saniona AB (publ).